Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-25-301025

Director acquired 4,183 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jerman Michael Allen Director 2025-11-21 Grant or award +4,183 $3.16 $13,218 4,183 D
Loading xslF345X05/ownership.xml…